PML/RARA, but not PML/RARAL73E, efficiently developed APL (Fig. 6a), in line with our observation that sumoylation of PML moiety is required for efficient leukemogenesis in vivo30. The gene discussed is PML; the disease is acute promyelocytic leukemia.